Management of Patients with Recurrent and Metachronous Oligometastatic Prostate Cancer in the Era of PSMA PET.

Sabbagh, Ali; Mohamad, Osama; Lichter, Katie E; Hope, Thomas A

Sabbagh, Ali; Mohamad, Osama; Lichter, Katie E; Hope, Thomas A.

Afiliação

Sabbagh A; Department of Radiation Oncology, University of California San Francisco, San Francisco, CA 94158, USA.
Mohamad O; Department of Radiation Oncology, University of California San Francisco, San Francisco, CA 94158, USA.
Lichter KE; Department of Urology, University of California San Francisco, San Francisco, CA 94143, USA.
Hope TA; Department of Radiation Oncology, University of California San Francisco, San Francisco, CA 94158, USA.

Cancers (Basel) ; 14(24)2022 Dec 15.

Article em En | MEDLINE | ID: mdl-36551678

Palavras-chave

PET PSMA; biochemical recurrence; oligometastasis; prostate cancer; radiotherapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies / Screening_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google